用真实世界Web应用程序数据库为儿科患者开发万科米辛人口药动力学模型
Kazutaka Oda1,2, Kensuke Shoji3, Kazuaki Matsumoto4
1Department of Pharmacy, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto city, Kumamoto 860-8556, Japan.
Journal of the Pediatric Infectious Diseases Society
|September 25, 2025
概括
一个新的人口药理动力学模型用于日本儿童的万科米辛剂量显示出出色的预测性能. 建议采用双点血样,以改善儿科患者的万科米辛清除率估计.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
- 药理动力学 药理动力学
背景情况:
- 日本化疗学会在度-时间曲线 (AUC) 导向的治疗药物监测 (PAT) 应用程序下开发了用于万科米辛剂量的实用领域.
- 在日本,PAT已经生成了一个大型的真实世界药理动力学数据库.
- 现有的儿科万科米辛模型需要针对日本儿童进行优化.
研究的目的:
- 开发一个人口药理动力学 (popPK) 模型,用于日本儿科的万科米辛剂量.
- 将新模型的性能与现有模型进行比较.
主要方法:
- 利用通过PAT.收集的1673名日本儿科患者 (3个月以上) 的现实数据库.
- 使用非线性混合效应建模进行了人群药理动力学分析.
- 将开发的模型与现有的5种药理动力学模型进行比较.
主要成果:
- 开发的popPK模型显示了强有力的先验预测性能,用于经验范胺剂量 (MPE:0.2μg/mL,MAPE:5.6μg/mL) 没有偏差.
- 图形诊断证实了最佳的先验预测.
- 在18.1%的患者中,与一点抽样相比,两点范科米辛抽样产生了显著不同的清除估计.
结论:
- 开发的popPK模型适用于日本儿科患者 (3个月以上) 的经验和贝叶斯指导的万科米辛剂量.
- 两点范胺取样提高了清除估计的准确性,并且在可行的情况下建议使用.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
193
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Drug Distribution
254
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
246
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
319
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
319


